In the world of biopharmaceutical innovation—where scientific rigor meets human hope—few names command the level of respect and admiration earned by Satish Singh. A transformative figure with more than four decades of experience, Dr. Singh has shaped the landscape of drug product development, advanced vaccine technology, and global regulatory strategy. His career is a powerful testament to perseverance, intellectual depth, and an unwavering commitment to advancing human health.
Today, he serves as Vice President at Astria Therapeutics, Inc., continuing a legacy defined by innovation, mentorship, and scientific excellence. But behind this distinguished prominence lies a journey grounded in grit, purpose, and a belief that science can change the world when driven by clarity of vision.
Early Academic Roots of Satish Singh: The Foundation of a Future Pioneer
The story of Satish Singh begins at IIT Delhi, where he earned his B.Tech. in Chemical Engineering in 1981—a degree that laid the foundation for a lifelong pursuit of scientific mastery. Fuelled by curiosity and a desire to push boundaries, he pursued an M.S. (1983) and Ph.D. (1987) in Chemical Engineering at Kansas State University.
These formative years were marked by intense research, rigorous experimentation, and a deepening appreciation for the complexities of biological systems. His early academic discipline would later become the backbone of his world-class expertise in biologics, protein science, computational analysis, and regulatory frameworks.
A Distinguished Career Spanning the World’s Leading Pharma Institutions
What sets Satish Singh apart is not simply the breadth of his experience—it is the depth of his impact across every organization he has touched.
Pfizer: Building a Legacy of Scientific Excellence
Before entering the global spotlight, Dr. Singh spent transformative years at Pfizer’s BioTherapeutics Pharmaceutical R&D unit, where he served as Research Fellow and Group Leader. Here, he led pioneering efforts in biologics development, protein stability, immunogenicity, and process analytics.
His work became integral to multiple BLA (Biologics License Application) and IND submissions—an achievement reserved for only the most influential scientific leaders.
Lonza Pharma & Biotech: Driving Innovation at Scale
At Lonza, one of the world’s most respected biopharmaceutical manufacturers, he spearheaded drug product development initiatives that strengthened industry standards for formulation, stability, and manufacturability.
His leadership was instrumental in developing scalable solutions for both biologics and small molecules—experience that would later prove crucial during global vaccine efforts.
Satish Singh: Moderna Therapeutics – Helping Shape the mRNA Revolution
The world came to understand the power of mRNA technology during the COVID-19 pandemic. But long before public headlines, scientists like Satish Singh were quietly laying the technical foundation that made this scientific miracle possible.
As Vice President of Drug Product Development at Moderna, and earlier as Distinguished Fellow, Dr. Singh led critical work in:
-
mRNA-LNP vaccine formulation
-
Analytical and biophysical characterization
-
Sterile product technology
-
Stability and cold-chain optimization
-
Regulatory strategy and submission readiness
His team’s contributions directly supported:
-
The rapid development of Moderna’s COVID-19 vaccine
-
The historical nine-month journey from concept to commercialization
-
Large-scale manufacturing readiness
-
Global deployment of mRNA vaccines that saved millions of lives
In his own words, the pandemic effort succeeded because “the knowledge and experience for all the elements required was already there—the achievement was in making it happen in months instead of years.”
Few individuals embody this truth more than Satish Singh.
Astria Therapeutics: A New Chapter of Leadership and Impact
Today, as Vice President at Astria Therapeutics, Inc., Dr. Singh continues to push the boundaries of therapeutic innovation. Astria’s focus on rare and immunological diseases aligns perfectly with his expertise in biologics, regulatory pathways, and advanced analytics.
His leadership is shaping next-generation treatments aimed at improving quality of life for patients who have long been underserved by conventional drug development.
A Scholar, Mentor, and Global Thought Leader
Beyond industry roles, Satish Singh is deeply committed to teaching and knowledge-sharing. He currently serves as Adjunct Professor at:
-
Uppsala University (Dept. of Physical Pharmaceutical Chemistry)
-
University of Michigan, College of Pharmacy
His academic contributions include:
-
Over 90 peer-reviewed scientific publications
-
Multiple authoritative book chapters
-
Key involvement in USP panels, including the writing of USP <787>, <1787>, and <771>
-
Frequent keynote speaker at international conferences, including several in India and at IIT Delhi
His election as an AAPS Fellow (2018) stands as a formal recognition of his extraordinary technical and scientific contributions.
Core Expertise That Defines a Global Innovator
Throughout his career, Satish Singh has shaped the scientific world through deep expertise in areas such as:
-
Biological and pharmaceutical drug product development
-
Ophthalmic and parenteral formulations
-
mRNA-LNP technology
-
Protein aggregation, immunogenicity & biophysical analysis
-
Impact of freezing processes on protein structure
-
Computational modeling for developability
-
Regulatory strategy and global quality systems
-
Analytical characterization and process design